Wednesday, April 3, 2019

Risky Stem-Cell Treatments Come Under F.D.A. Scrutiny — Again by DENISE GRADY


By DENISE GRADY

Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout its rules.

Published: April 2, 2019 at 08:00PM

from NYT Health https://ift.tt/2UfjXIc
via IFTTT



from WordPress https://ift.tt/2uJNEC7
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)